|
Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
|
1
|
Resverlogix Corp.
|
Mar 23, 2020 08:12PM
|
|
Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
|
1
|
Resverlogix Corp.
|
Mar 23, 2020 09:05PM
|
|
Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
|
1
|
Resverlogix Corp.
|
Mar 23, 2020 09:31PM
|
|
Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
|
1
|
Resverlogix Corp.
|
Mar 23, 2020 09:57PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
1
|
Resverlogix Corp.
|
Mar 24, 2020 09:54AM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
1
|
Resverlogix Corp.
|
Mar 24, 2020 04:10PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
1
|
Resverlogix Corp.
|
Mar 24, 2020 04:37PM
|
|
Re: Huge difference....
|
1
|
Resverlogix Corp.
|
Mar 25, 2020 07:38PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
6
|
Resverlogix Corp.
|
Mar 26, 2020 05:37AM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
7
|
Resverlogix Corp.
|
Mar 27, 2020 10:19AM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
3
|
Resverlogix Corp.
|
Mar 27, 2020 10:58AM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
3
|
Resverlogix Corp.
|
Mar 27, 2020 11:26AM
|
|
Re: Is anyone else seeing 0 lots available on the ask at $1.07?
|
2
|
Resverlogix Corp.
|
Mar 27, 2020 12:17PM
|
|
Exempt Distribution 45-106F1
|
7
|
Resverlogix Corp.
|
Mar 27, 2020 12:44PM
|
|
Re: Is anyone else seeing 0 lots available on the ask at $1.07?
|
|
Resverlogix Corp.
|
Mar 27, 2020 12:56PM
|
|
Re: Exempt Distribution 45-106F1
|
1
|
Resverlogix Corp.
|
Mar 27, 2020 12:59PM
|
|
Re: ACC/WCC Virtual 2020
|
2
|
Resverlogix Corp.
|
Mar 28, 2020 08:38AM
|
|
Re: ACC/WCC Virtual 2020
|
2
|
Resverlogix Corp.
|
Mar 28, 2020 09:55AM
|
|
Re: ACC/WCC Virtual 2020
|
3
|
Resverlogix Corp.
|
Mar 29, 2020 09:20AM
|
|
Re: Finance
|
1
|
Resverlogix Corp.
|
Mar 29, 2020 05:37PM
|
